13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001590144
Total reported value
$37.0M
$37.0M
18 檔
60.0%
During the Q4 2025 filing period, Pura Vida Investments, LLC (CIK: 0001590144) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $37.0M across 18 reported positions.
In Q4 2025, Pura Vida Investments, LLC displayed an active expansion posture, initiating 10 new positions and adding to 0 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BBNX | Beta Bionics Inc | Stock-Other | 32.03% | -7.03% | — | |
| 2 | IMDX | Insight Molecular Diagnostic | Stock-Other | 26.55% | -13.15% | — | |
| 3 | ✓ | Establishment Labs Holdings In | Stock-Other | 12.26% | -6.73% | — | |
| 4 | CAI | Caris Life Sciences Inc | Stock-Other | 9.07% | -9.58% | — | |
| 5 | NSPR | Inspiremd Inc | Stock-Other | 3.00% | -4.09% | — | |
| 6 | MSFT | Microsoft CORP | Stock-Tech | 2.17% | -1.45% | — | |
| 7 | NTRA | Natera Inc | Stock-Healthcare | 2.14% | -2.26% | — | |
| 8 | JPM | Jpmorgan Chase & Co | Stock-Financials | 1.63% | -1.48% | — | |
| 9 | NVDA | Nvidia CORP | Stock-Tech | 1.62% | -1.69% | — | |
| 10 | MGX | Metagenomi Therapeutics Inc | Stock-Other | 1.60% | -1.53% | — | |
| 11 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 1.40% | -1.14% | — | |
| 12 | AAPL | Apple Inc | Stock-Tech | 1.18% | -1.08% | — | |
| 13 | OM | Outset Medical Inc | Stock-Other | 1.16% | -1.18% | — | |
| 14 | ADI | Analog Devices Inc | Stock-Tech | 1.01% | -1.07% | — | |
| 15 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 0.86% | -0.83% | — | |
| 16 | LIN | Linde plc | Stock-Materials | 0.80% | -0.97% | — | |
| 17 | DHR | Danaher CORP | Stock-Healthcare | 0.77% | — | — | |
| 18 | ASML | ASML Holding N.V. | Stock-Tech | 0.76% | -0.67% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | IMDX | Insight Molecular Diagnostic | +7.4% | — | Unchanged |
| 2 | ✓ | Establishment Labs Holdings In | +1% | — | Unchanged |
| 3 | NTRA | Natera Inc | -0.3% | — | Unchanged |
| 4 | BBNX | Beta Bionics Inc | -2% | — | Unchanged |
| 5 | MGX | Metagenomi Therapeutics Inc | -2.2% | — | Unchanged |
| 6 | NSPR | Inspiremd Inc | -3.6% | — | Unchanged |
| 7 | OM | Outset Medical Inc | -4.9% | — | Unchanged |
| 8 | CAI | Caris Life Sciences Inc | -7.5% | — | Unchanged |
| 9 | MSFT | Microsoft CORP | — | NEW | New buy |
| 10 | JPM | Jpmorgan Chase & Co | — | NEW | New buy |
| 11 | NVDA | Nvidia CORP | — | NEW | New buy |
| 12 | GOOG | Alphabet Inc-cl C | — | NEW | New buy |
| 13 | AAPL | Apple Inc | — | NEW | New buy |
| 14 | ADI | Analog Devices Inc | — | NEW | New buy |
| 15 | AMZN | Amazon.com Inc | — | NEW | New buy |
| 16 | LIN | Linde plc | — | NEW | New buy |
| 17 | DHR | Danaher CORP | — | NEW | New buy |
| 18 | ASML | ASML Holding N.V. | — | NEW | New buy |
According to official SEC Form 13F filings, Pura Vida Investments, LLC reported a total U.S. public equity portfolio value of $37.0M across 18 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including BBNX, IMDX, ESTABLISHMENT LABS HOLDINGS IN) accounted for 60.0% of total reported equity market value during Q4 2025.
Top New Position Initiated
MSFT
市值: $580.3K
During Q4 2025, Pura Vida Investments, LLC's top holdings by market value included BBNX (32.0%)、IMDX (26.6%)、ESTABLISHMENT LABS HOLDINGS IN (12.3%). The largest single position, BBNX, represented 32.0% of total portfolio value.
In Q4 2025, Pura Vida Investments, LLC made 10 total portfolio adjustments, initiating 10 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.